| pubmed-article:15515782 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15515782 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:15515782 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:15515782 | lifeskim:mentions | umls-concept:C0002199 | lld:lifeskim |
| pubmed-article:15515782 | lifeskim:mentions | umls-concept:C0031069 | lld:lifeskim |
| pubmed-article:15515782 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:15515782 | lifeskim:mentions | umls-concept:C1304680 | lld:lifeskim |
| pubmed-article:15515782 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
| pubmed-article:15515782 | lifeskim:mentions | umls-concept:C1261512 | lld:lifeskim |
| pubmed-article:15515782 | lifeskim:mentions | umls-concept:C0699795 | lld:lifeskim |
| pubmed-article:15515782 | pubmed:issue | 4 Suppl 34 | lld:pubmed |
| pubmed-article:15515782 | pubmed:dateCreated | 2004-11-1 | lld:pubmed |
| pubmed-article:15515782 | pubmed:abstractText | About a quarter of familial Mediterranean fever (FMF) patients are partially or totally resistant to colchicine. A previous observation reported that acute attacks may be shortened by administration of interferon alpha (IFN). | lld:pubmed |
| pubmed-article:15515782 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15515782 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15515782 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15515782 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15515782 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15515782 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15515782 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15515782 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15515782 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15515782 | pubmed:issn | 0392-856X | lld:pubmed |
| pubmed-article:15515782 | pubmed:author | pubmed-author:AkarSS | lld:pubmed |
| pubmed-article:15515782 | pubmed:author | pubmed-author:KirkaliGG | lld:pubmed |
| pubmed-article:15515782 | pubmed:author | pubmed-author:TankurtEE | lld:pubmed |
| pubmed-article:15515782 | pubmed:author | pubmed-author:HawkinsP NPN | lld:pubmed |
| pubmed-article:15515782 | pubmed:author | pubmed-author:TuncaMM | lld:pubmed |
| pubmed-article:15515782 | pubmed:author | pubmed-author:GallimoreJ... | lld:pubmed |
| pubmed-article:15515782 | pubmed:author | pubmed-author:GönenOO | lld:pubmed |
| pubmed-article:15515782 | pubmed:author | pubmed-author:AkhunlarHH | lld:pubmed |
| pubmed-article:15515782 | pubmed:author | pubmed-author:SoytürkMM | lld:pubmed |
| pubmed-article:15515782 | pubmed:author | pubmed-author:SEGARL FLF | lld:pubmed |
| pubmed-article:15515782 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15515782 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:15515782 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15515782 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15515782 | pubmed:pagination | S37-40 | lld:pubmed |
| pubmed-article:15515782 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:15515782 | pubmed:meshHeading | pubmed-meshheading:15515782... | lld:pubmed |
| pubmed-article:15515782 | pubmed:meshHeading | pubmed-meshheading:15515782... | lld:pubmed |
| pubmed-article:15515782 | pubmed:meshHeading | pubmed-meshheading:15515782... | lld:pubmed |
| pubmed-article:15515782 | pubmed:meshHeading | pubmed-meshheading:15515782... | lld:pubmed |
| pubmed-article:15515782 | pubmed:meshHeading | pubmed-meshheading:15515782... | lld:pubmed |
| pubmed-article:15515782 | pubmed:meshHeading | pubmed-meshheading:15515782... | lld:pubmed |
| pubmed-article:15515782 | pubmed:meshHeading | pubmed-meshheading:15515782... | lld:pubmed |
| pubmed-article:15515782 | pubmed:meshHeading | pubmed-meshheading:15515782... | lld:pubmed |
| pubmed-article:15515782 | pubmed:meshHeading | pubmed-meshheading:15515782... | lld:pubmed |
| pubmed-article:15515782 | pubmed:meshHeading | pubmed-meshheading:15515782... | lld:pubmed |
| pubmed-article:15515782 | pubmed:meshHeading | pubmed-meshheading:15515782... | lld:pubmed |
| pubmed-article:15515782 | pubmed:meshHeading | pubmed-meshheading:15515782... | lld:pubmed |
| pubmed-article:15515782 | pubmed:meshHeading | pubmed-meshheading:15515782... | lld:pubmed |
| pubmed-article:15515782 | pubmed:articleTitle | The effect of interferon alpha administration on acute attacks of familial Mediterranean fever: A double-blind, placebo-controlled trial. | lld:pubmed |
| pubmed-article:15515782 | pubmed:affiliation | Dokuz Eylül University School of Medicine, Department of Internal Medicine, Izmir, Turkey. tunca@superonline.com | lld:pubmed |
| pubmed-article:15515782 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15515782 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15515782 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| pubmed-article:15515782 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15515782 | lld:pubmed |
